Skip to main content
. Author manuscript; available in PMC: 2022 Apr 9.
Published in final edited form as: ACS Infect Dis. 2021 Mar 10;7(4):894–905. doi: 10.1021/acsinfecdis.0c00917

Figure 3.

Figure 3.

MIC versus ALogP for compounds 1-47 against selected strains of E.coli and K.pneumoniae with reduced susceptibility to polymyxins, coloured on Dap or Dab residue adjacent to the heptapeptide core.